Mankind Pharma Limited (MANKIND.BO)
INR 2351.3
(1.6%)
INR 2351.3
(1.6%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 23.15 Billion INR | 30.78% |
| 2022 | 17.7 Billion INR | -48.44% |
| 2021 | 34.33 Billion INR | 23.37% |
| 2020 | 27.82 Billion INR | 12.53% |
| 2019 | 24.73 Billion INR | 6.63% |
| 2018 | 23.19 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 7.65 Billion INR | 44.08% |
| 2023 Q1 | 11.91 Billion INR | 155.39% |
| 2023 Q3 | 12.82 Billion INR | -1.12% |
| 2023 FY | 23.15 Billion INR | 30.78% |
| 2023 Q4 | 5.31 Billion INR | -58.58% |
| 2023 Q2 | 12.97 Billion INR | 8.89% |
| 2022 Q4 | 4.66 Billion INR | -52.7% |
| 2022 Q2 | 11.07 Billion INR | 5.82% |
| 2022 Q3 | 9.86 Billion INR | -10.95% |
| 2022 FY | 17.7 Billion INR | -48.44% |
| 2022 Q1 | 10.46 Billion INR | 14.49% |
| 2021 Q4 | 9.14 Billion INR | 0.0% |
| 2021 FY | 34.33 Billion INR | 23.37% |
| 2020 FY | 27.82 Billion INR | 12.53% |
| 2019 FY | 24.73 Billion INR | 6.63% |
| 2018 FY | 23.19 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 84.983% |
| NATCO Pharma Limited | 10.05 Billion INR | -130.192% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -1550.48% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -2356.789% |
| Achyut Healthcare Limited | 1.6 Million INR | -1438853.014% |
| Ajanta Pharma Limited | 30.46 Billion INR | 23.996% |
| Alkem Laboratories Limited | 32.83 Billion INR | 29.488% |
| Alpa Laboratories Limited | 156.14 Million INR | -14727.537% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | -45.893% |
| AstraZeneca Pharma India Limited | 2.6 Billion INR | -790.354% |
| Aurobindo Pharma Limited | 39.23 Billion INR | 40.99% |
| Bajaj HealthCare Limited | 985.34 Million INR | -2249.71% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -1531.369% |
| Brooks Laboratories Limited | 51.18 Million INR | -45137.894% |
| Divi's Laboratories Limited | 14.17 Billion INR | -63.393% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 75.852% |
| Eris Lifesciences Limited | 4.94 Billion INR | -368.4% |
| FDC Limited | 5.34 Billion INR | -332.881% |
| Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 65.732% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -98.895% |
| Granules India Limited | 7.18 Billion INR | -222.355% |
| Gufic Biosciences Limited | 1.07 Billion INR | -2048.327% |
| Hester Biosciences Limited | 908.84 Million INR | -2447.506% |
| Indoco Remedies Limited | 4.74 Billion INR | -387.552% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -989.96% |
| Ipca Laboratories Limited | 13.91 Billion INR | -66.388% |
| Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | -2893.594% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -50061.959% |
| Lasa Supergenerics Limited | 291.17 Million INR | -7851.518% |
| Laurus Labs Limited | 3.01 Billion INR | -668.99% |
| Lupin Limited | 95.67 Billion INR | 75.8% |
| Medicamen Biotech Limited | 335.16 Million INR | -6807.826% |
| Medico Remedies Limited | 161.84 Million INR | -14205.599% |
| Megasoft Limited | 49.52 Million INR | -46646.799% |
| Piramal Pharma Limited | 19.91 Billion INR | -16.264% |
| RPG Life Sciences Limited | 1.63 Billion INR | -1315.638% |
| Sigachi Industries Limited | 579.88 Million INR | -3892.632% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -652.495% |
| Unichem Laboratories Limited | 6.72 Billion INR | -244.234% |
| Wanbury Limited | 1.16 Billion INR | -1894.333% |
| Windlas Biotech Limited | 1 Billion INR | -2200.3% |
| ZIM Laboratories Limited | 1.01 Billion INR | -2185.432% |
| Zydus Lifesciences Limited | 43.17 Billion INR | 46.373% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -672.944% |
| Amrutanjan Health Care Limited | 1.09 Billion INR | -2006.734% |
| Bal Pharma Limited | 389.89 Million INR | -5838.278% |
| Strides Pharma Science Limited | 9.16 Billion INR | -152.696% |
| Venus Remedies Limited | 1.91 Billion INR | -1108.211% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -653.082% |
| Nectar Lifesciences Limited | 625.55 Million INR | -3601.184% |
| Shilpa Medicare Limited | 2.18 Billion INR | -961.766% |
| Aarti Drugs Limited | 1.16 Billion INR | -1883.141% |
| IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | -2007.094% |
| Suven Life Sciences Limited | 109.75 Million INR | -20995.903% |
| Ind-Swift Limited | 946.56 Million INR | -2345.971% |
| Valiant Laboratories Limited | 36.28 Million INR | -63701.025% |
| J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | -175.069% |
| Solara Active Pharma Sciences Limited | 4.57 Billion INR | -405.552% |
| Themis Medicare Limited | 782.85 Million INR | -2857.477% |
| Hikal Limited | 2.48 Billion INR | -831.198% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | -8.079% |
| Sequent Scientific Limited | 2.9 Billion INR | -697.873% |
| Novartis India Limited | 470.1 Million INR | -4825.07% |
| Wockhardt Limited | 6.4 Billion INR | -261.762% |
| Jubilant Pharmova Limited | 14.45 Billion INR | -60.182% |
| Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -142732.72% |
| Neuland Laboratories Limited | 2.92 Billion INR | -690.265% |
| Morepen Laboratories Limited | 1.98 Billion INR | -1064.948% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -5513.782% |
| Mangalam Drugs & Organics Limited | 676.14 Million INR | -3324.219% |